Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Biolase Obtains FDA Clearances for New Diode Lasers
Oct 1999
SAN CLEMENTE, Calif., Oct. 1 -- Biolase Technology Inc. has obtained clearances from the US Food and Drug Administration to market the company's new lightweight diode lasers, TwiLite and HyLite, for use in dental cosmetic and soft tissue procedures. Biolase also received clearances that include indications for use of the new lasers in arthroscopy, gastroenterology, ENT, general surgery, plastic surgery, dermatology, GI/GU, gynecology, podiatry, neurosurgery, ophthalmology, urology, and pulmonary surgery.
According to Jeffrey W. Jones, president and CEO of Biolase, cosmetic and painless procedures represent the fastest-growing and most profitable segment of the dental market. Jones also noted that the new lasers' consumable handpieces, fibers, and tips would provide the company with a recurring stream of revenue.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.